SCHEMBL961206

SCHEMBL961206

COCCNC(=O)c1cccc(-c2cccc(OCCc3cccc(OC)c3)n2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 2/20 0.63
AURKA O14965 1/20 0.51
ALDH1A1 P00352 1/20 0.49
MMP13 P45452 1/20 0.49
TP53 P04637 3/20 0.49
LOX P28300 2/20 0.48
LOXL2 Q9Y4K0 2/20 0.48
ROCK2 O75116 2/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
CYP1A2 P05177 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NAMPT P43490 1/20 0.47
ROCK1 Q13464 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL959859 0.93 GPR52 (0.73) GPR52AURKAALDH1A1MMP13TP53
SCHEMBL12918938 0.93 GPR52 (0.61) GPR52AURKAALDH1A1MMP13TP53
SCHEMBL3402485 0.93 GPR52 (0.61) GPR52AURKAALDH1A1MMP13TP53
Hydrochloric Acid SCHEMBL958163 0.92 GPR52 (0.60) GPR52AURKAALDH1A1MMP13TP53
SCHEMBL959095 0.90 GPR52 (0.59) GPR52AURKAALDH1A1MMP13TP53
SCHEMBL958255 0.89 GPR52 (0.56) GPR52AURKAMMP13TP53ROCK2
SCHEMBL12918937 0.89 GPR52 (0.59) GPR52AURKAMMP13TP53ROCK2
SCHEMBL961496 0.88 SMYD2 (0.56) GPR52CYP2C19
SCHEMBL12919063 0.88 GPR52 (0.60) GPR52ALDH1A1TP53RAB9ANPC1
SCHEMBL961839 0.86 GPR52 (0.57) GPR52AURKAALDH1A1MMP13TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 GPR52 23/4885AURKA 4359/4885ALDH1A1 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.